UMB Bank’s Utah Medical Products UTMD Stock Holding History

UMB Bank’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-152	Closed	-$8.65K	–	2200
2025 Q2	$8.65K	Buy	+152	New	+$8.27K	﹤0.01%	1655

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

UMB Bank's UTMD Position: Q3 2025 in Review

UMB Bank sold out of Utah Medical Products (UTMD) in Q3 2025, closing a stake of 152 shares — an estimated $8.65K sold.

UMB Bank first reported a position in UTMD in Q2 2025 and held it in 1 quarter. The position peaked at $8.65K in Q2 2025. 117 funds tracked by Wall St. Rank hold UTMD as of Q3 2025.

UMB Bank reported no remaining Utah Medical Products position as of Q3 2025 after selling out during the quarter.
UMB Bank sold 152 Utah Medical Products shares in Q3 2025, an estimated $8.65K.
UMB Bank first reported a position in Utah Medical Products in Q2 2025 and held it in 1 quarter.
UMB Bank's Utah Medical Products position peaked at $8.65K in Q2 2025.
117 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2025.

Based on UMB Bank's 13F filing for Q3 2025, filed 4 Nov 2025.